Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner.

‘Surprising’ Alzheimer’s disease discovery raises hopes of treatment breakthrough

‘Surprising’ Alzheimer’s disease discovery raises hopes of treatment breakthrough

A study using mice has uncovered a possible new cause of Alzheimer’s disease, and suggests a drug currently being investigated in human clinical trials to treat cancer could prevent the illness.

The research has been heralded as offering hope of finding new treatments for dementia, an illness that currently affects 850,000 people in the UK.

The findings, by Duke University in America and published in the Journal of Neuroscience, are surprising, according to one of the authors, as they contradict current thinking on the disease.

The research suggests that with Alzheimer’s disease certain immune cells that normally protect the brain begin abnormally to consume an important nutrient called arginine.

By blocking this process using the drug difluoromethylornithine (DFMO), memory loss and a build-up of sticky proteins known as brain plaques, were prevented.

The study used a type of mouse in which a number of important genes have been swapped to make the animal’s immune system more similar to a human’s.

Senior author Carol Colton, professor of neurology at the Duke University School of Medicine, and a member of the Duke Institute for Brain Sciences, said: “If indeed arginine consumption is so important to the disease process, maybe we could block it and reverse the disease.”

It was previously thought the brain releases molecules which ramp up the immune system, apparently damaging the brain, but the study found a heightened expression of genes associated with the suppression of the immune system.

Author Matthew Kan said: “It’s surprising, because (suppression of the immune system is) not what the field has been thinking is happening in AD (Alzheimer’s disease).”

Mice which had been given the drug DFMO to block arginase, an enzyme that breaks down arginine, were found to perform better in memory tests.

“All of this suggests to us that if you can block this local process of amino acid deprivation, then you can protect – the mouse, at least – from Alzheimer’s disease,” Mr Kan said.

Prof Colton added: “We see this study opening the doors to thinking about Alzheimer’s in a completely different way, to break the stalemate of ideas in AD.”

It is thought that this year one person every three minutes will develop dementia. The disease currently costs the UK economy more than £26 billion each year.

The research has been welcomed by the Alzheimer’s Society.

Head of research Dr James Pickett said: “This study in animals joins some of the dots in our incomplete understanding of the processes that cause Alzheimer’s disease, in particular around the role played by the immune system.

“Using a new animal model of Alzheimer’s, the researchers have found that depletion of a nutrient called arginine occurs in the damaged brain areas.

“Blocking the use of arginine reduced some of the disease hallmarks and improved memory performance, offering hope that these findings could lead to new treatments for dementia.

“Importantly, these new findings reflect earlier observations that arginine is reduced in the brains of people with Alzheimer’s disease.

“The next step would be to show that targeting arginine metabolism in the brain can reduce the death of brain cells, as this was not shown in the current study.”

Already a subscriber? Sign in

[[title]]

[[text]]